1. Home
  2. NTNX vs ARWR Comparison

NTNX vs ARWR Comparison

Compare NTNX & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutanix Inc.

NTNX

Nutanix Inc.

HOLD

Current Price

$45.23

Market Cap

9.1B

Sector

Technology

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$75.15

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTNX
ARWR
Founded
2009
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
9.3B
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
NTNX
ARWR
Price
$45.23
$75.15
Analyst Decision
Buy
Strong Buy
Analyst Count
19
10
Target Price
$62.29
$83.40
AVG Volume (30 Days)
2.8M
1.7M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
227.45
99.80
EPS
0.57
N/A
Revenue
$2,537,927,000.00
$16,142,321.00
Revenue This Year
$13.44
N/A
Revenue Next Year
$13.03
N/A
P/E Ratio
$84.95
N/A
Revenue Growth
18.11
N/A
52 Week Low
$34.01
$14.30
52 Week High
$82.42
$82.26

Technical Indicators

Market Signals
Indicator
NTNX
ARWR
Relative Strength Index (RSI) 56.30 53.86
Support Level $35.23 $70.79
Resistance Level $53.75 $76.45
Average True Range (ATR) 1.67 4.05
MACD 0.19 -0.69
Stochastic Oscillator 47.85 43.70

Price Performance

Historical Comparison
NTNX
ARWR

About NTNX Nutanix Inc.

Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company operates a single operating and reportable segment based on a subscription business model. It conducts business in the United States, Europe, the Middle East and Africa, Asia Pacific, and other Americas, with key revenue generated from the United States.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: